Hedera Dx
Hedera Dx was created in 2021 with the mission to give access to liquid biopsy technologies to patients at risk of or already suffering from cancer.
Visit websiteLausanne, Switzerland
Healthtech
Funding summary
- Total raised
- €29.0M
- Funding rounds
- 2
Investors in Hedera Dx
Investors on record for Hedera Dx. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Hedera Dx?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors